| Literature DB >> 26779378 |
Yan Kong1, Jin Wang1, Huan Li1, Peng Guo1, Jian-Fa Xu1, He-Lin Feng1.
Abstract
Renal cell carcinoma (RCC) accounts for approximately 3% of all cancer cases. RCCs usually metastasize to the lungs, bones, liver, or brain. Only <1% of patients with bone metastases manifested clavicular RCC metastases. Thus, clavicular metastasis as the initial presentation of RCC is extremely rare. We report a patient with RCC metastasis to the left clavicle, which was first presented with pain caused by a pathological fracture. Magnetic resonance image revealed a renal tumor, and technetium-99m-methylene diphosphonate bone scintigraphy showed multiple osseous metastases. The patient eventually underwent surgery to remove the lateral end of the left clavicle and right kidney. Histopathology revealed renal tumor and clear cell carcinoma in the clavicle. Finally, we review 17 cases of clavicular metastases originating from different malignancies.Entities:
Keywords: Clavicle; metastasis; pathological fracture; renal cell carcinoma (RCC)
Year: 2015 PMID: 26779378 PMCID: PMC4706516 DOI: 10.7497/j.issn.2095-3941.2015.0033
Source DB: PubMed Journal: Cancer Biol Med ISSN: 2095-3941 Impact factor: 4.248
Figure 1X-ray and MRI results of a 64-year-old patient. (A) X-ray result displayed an osteolytic lesion in the lateral third of left clavicle. (B,C) T2-weight MRI to the left clavicle revealed high-intensity lesions.
Figure 2A tumor in the right renal cortex, spreading to the renal capsule. (A) CT. (B) MRI.
Figure 3Technetium-99m–methylene diphosphonate bone scintigraphy revealed multiple radioactive foci.
Figure 4Histopathology of clavicle revealed clear cell carcinoma (H&E staining, 200×).
Review of the previously reported cases of clavicular metastasis
| Age of diagnosis (years) | FS | Sex | Side/location | Primary sites (histology) | Solitary or multiple | Ref. |
|---|---|---|---|---|---|---|
| 48 | N | Female | L/medial | RCC | Multiple | |
| 58 | Y | Male | R/medial, lateral | RCC | Solitary | |
| 62 | Y | Male | R/middle | RCC | Solitary | |
| 34 | N | Male | R/medial | Uveal (melanoma) | Solitary | |
| 41 | N | Female | L/medial | Thyroid (follicular) | Solitary | |
| 48 | N | Male | R/- | Tonsil (SCC) | Multiple | |
| 67 | Y | Male | R/medial | HCC (epithelial) | Solitary | |
| 68 | N | Male | R/medial | Colon (AD) | Multiple | |
| 67 | N | Male | L/medial | Cecum | Multiple | |
| 55 | N | Female | - | Unknown (AD) | Multiple | |
| 67 | N | Man | L/medial | Larynx (SCC) | Multiple | |
| 73 | N | Female | L/medial | Adnexa (microcystic) | Multiple | |
| 20 | N | Male | R/medial | Trigeminal (epithelioid schwannoma) | Multiple | |
| 67 | N | Male | L/entire | Prostate | Solitary | |
| 52 | N | Male | R/lateral | Adrenal (pheochromocytoma) | Solitary | |
| 40 | N | Female | R/medial | Thyroid | Multiple | |
| 71 | Y | Male | - | RCC | Multiple |
FS, first presentation; RCC, renal cell carcinoma; SCC, squamous cell carcinoma; HCC, hepatocellular carcinoma; AD, adenocarcinoma.